L03AB07 • interferon beta 1A • Antineoplastic and immunomodulating agents | Immunostimulants | Interferons
Interferon beta-1A is a medication used for the treatment of relapsing multiple sclerosis. It works by modulating the immune response, reducing the frequency of relapses and slowing disease progression.
The medication is administered as a subcutaneous or intramuscular injection, as directed by a doctor, usually once or several times a week. It is important for patients to follow the treatment regimen and undergo regular check-ups.
Patients should be aware of potential side effects, such as flu-like symptoms, injection site reactions, or fatigue. It is important to inform the doctor of any unusual symptoms.
Common side effects include flu-like symptoms, injection site reactions, and fatigue. In rare cases, severe reactions such as depression or liver impairment may occur. Patients should be informed of these risks before starting treatment.
Substance: interferon beta 1A
Date of last drug list: 01-07-2013
Commercial code: W08473001
Concentration: 44mcg
Pharmaceutical form: injectible solution
Quantity: 1
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).